Triple
T16851825
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Velpatasvir |
E409693
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | NS5A inhibitor |
C37924
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: NS5A inhibitor Context triple: [Velpatasvir, instanceOf, NS5A inhibitor]
-
A.
neuraminidase inhibitor
A neuraminidase inhibitor is an antiviral drug that blocks the activity of the viral neuraminidase enzyme, preventing the release and spread of influenza viruses from infected cells.
-
B.
CDK4/6 inhibitor
A CDK4/6 inhibitor is a targeted anticancer drug that blocks cyclin-dependent kinases 4 and 6 to halt cell cycle progression from G1 to S phase, thereby inhibiting tumor cell proliferation.
-
C.
Bruton tyrosine kinase inhibitor
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
-
D.
pegylated interferon beta-1a
Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
-
E.
angiopoietin-2 inhibitor
An angiopoietin-2 inhibitor is a therapeutic agent that selectively blocks the activity of angiopoietin-2 to stabilize blood vessels, reduce pathological angiogenesis, and modulate vascular inflammation in diseases such as cancer and ocular disorders.
- F. None of above. chosen
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d88395e6c88190b22730f335107c14 |
completed | April 10, 2026, 4:59 a.m. |
Created at: April 10, 2026, 5:24 a.m.